Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population

scientific article published on 14 March 2009

Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JURO.2009.01.029
P8608Fatcat IDrelease_ajnbi3drhnajrd5uzrbn3u4nsy
P932PMC publication ID3677190
P698PubMed publication ID19286205
P5875ResearchGate publication ID24200793

P50authorDonna AnkerstQ58241772
P2093author name stringIan M Thompson
Brad H Pollock
Dipen J Parekh
Prakash Vijay Nair
Ryan Miyamoto
P2860cites workCancer statistics, 2008Q27860585
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.Q34291551
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliterQ34323096
The influence of finasteride on the development of prostate cancerQ34534815
Controversies regarding screening for prostate cancerQ36861719
Active surveillance for favorable risk prostate cancer: rationale, risks, and resultsQ37019376
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trialQ39710858
Assessing prostate cancer risk: results from the Prostate Cancer Prevention TrialQ39752227
Assessing individual risk for prostate cancerQ39809092
Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.Q39842824
The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer.Q39842989
The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), RotterdamQ39843624
Radical Prostatectomy for Impalpable Prostate Cancer: The Johns Hopkins Experience With Tumors Found on Transurethral Resection (Stages T1a and T1b) and on Needle Biopsy (Stage T1c)Q40393478
Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patientsQ41467228
Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature.Q46032140
Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuationsQ73444570
European Randomized Study of Screening for Prostate Cancer: achievements and presentationQ76382506
Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcomeQ79426082
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)2071-5; discussion 2076
P577publication date2009-03-14
P1433published inJournal of UrologyQ15709979
P1476titleYearly prostate specific antigen and digital rectal examination fluctuations in a screened population
P478volume181

Reverse relations

cites work (P2860)
Q36986295Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
Q37537786Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis
Q36235155Prostate cancer screening trends in a large, integrated health care system
Q40852349Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer
Q36942855Trends and co-trends of prostate-specific antigen and body mass index in a screened population
Q36607766Tumor markers in prostate cancer I: blood-based markers
Q34164258What happens after an elevated PSA test: the experience of 13,591 veterans

Search more.